IP Library Granted Patent US 10,883,109
Granted Patent B2
US 10,883,109 · App. 15/713,081 · Granted Jan 5, 2021

Methods of modulating mRNA stability and protein expression

Inventors: Jeffery M. Coller (Novelty, OH); Kristian E. Baker (Novelty, OH)
Assignee: CASE WESTERN RESERVE UNIVERSITY
C12N15/68C12N9/2428C12N15/81C12N15/85C12N2800/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,883,109
App. No.
15/713,081
Granted
Jan 5, 2021
Kind
B2
Abstract

A synthetic cDNA which encodes a protein wherein at least one optimal or non-optimal codon in a wild type DNA encoding the protein has been replaced respectively with one or more non-optimal codons or optimal codons encoding the same amino acid.

Claims (10)

1. A method of modulating the expression of a recombinant protein in a host cell, the method comprising:

identifying optimal and non-optimal codons in a wild type cDNA sequence that encodes the protein,

preparing a synthetic cDNA sequence by replacing one or more of the optimal codons of the wild type cDNA with a non-optimal codon encoding the same amino add as the replaced optimal codon or replacing one or more of the non-optimal codons of the wild type cDNA with an optimal codon encoding the same amino add as the replaced non-optimal codon,

transfecting the host cell with the synthetic cDNA, wherein the replacement of the one or more codons from the cDNA sequence enhances expression of the recombinant protein in the host cell at least about 10% compared to the nucleic sequence prior to replacement, wherein the one or more optimal codons are selected from the group consisting of pct (Alanine), ggt (Glycine), gtc (Valine), ttg (Leucine), gtt (Valine), gcc (Alanine), cca (Proline), act (Threonine), tct (Serine), tcc (Serine), acc (Threonine), atc (Isoleucine), aag (Lysine), tac (Tyrosine), ttc (Phenylalanine), gaa (Glutamic Acid), cgt (Arginine), caa (Glutamine), cac (Histidine), aac (Asparagine), gac (Aspartic Add), att (Isoleucine), aga (Arginine), and tgt (Cysteine); and the one or more non-optimal codons are selected from the group consisting of cct (Proline), ggc (Glycine), igg (Tryptophan), tta (Leucine), gat (Aspartic Add), atg (Methionine), ttt (Phenylalanine), tgc (Cysteine), cat (Histidine), gca (Alanine), tat (Tyrosine), ccc (Proline), ggg (Glycine), gtg (Valine), gcg (Alanine), cgc (Arginine), tca (Serine), gag (Glutamic Acid), gga (Glycine), tcg (Serine), cgg (Arginine), aat (Asparagine), ctt (Leucine), cta (Leucine), cag (Glutamine), ctc (Leucine), aca (Threonine), age: (Serine), aaa (Lysine), agt (Serine), acg (Threonine), ctg (Leucine), ccg (Proline), gta (Valine), agg (Arginine), cga (Arginine), and ata (isoleucine), and

expressing the recombinant protein.

2. The method of claim 1 , wherein one or more of the non-optimal codons is replaced with an optimal codon encoding the same amino acid as the replaced one or more non-optimal codons so that the synthetic cDNA sequence has more than about 70% optimal codons.

3. The method of claim 1 , wherein the cell is a yeast cell.

4. The method of claim 1 , wherein the cell is a mammalian cell.

5. The method of claim 1 , wherein the cell is transfected with a vector including the synthetic cDNA.

6. The method of claim 5 , wherein the vector is a mammalian expression vector.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2020
From: COLLER, JEFFERY M.; BAKER, KRISTIAN E.
To: CASE WESTERN RESERVE UNIVERSITY
Reel/Frame 053653/0221 →
CONFIRMATORY LICENSE Recorded Jul 16, 2018
From: CASE WESTERN RESERVE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046553/0804 →
Continuity (5)
Continuation In Part 15557412
Provisional Application 62398281 · Sep 22, 2016
Provisional Application 62130398 · Mar 9, 2015
Related Publication 20180135061A1 · May 17, 2018
Related Publication 20200140872A9 · May 7, 2020